| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 665 |
| 1 | OMEPRAZOLE MAGNESIUM | 520 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 420 |
| 3 | OMEPRAZOLE | 329 |
| 4 | PANTOPRAZOLE | 268 |
| 5 | ESOMEPRAZOLE SODIUM | 263 |
| 6 | ESOMEPRAZOLE | 196 |
| 7 | LANSOPRAZOLE DELAYED RELEASE | 166 |
| 8 | PANTOPRAZOLE SODIUM | 148 |
| 9 | DEXLANSOPRAZOLE | 67 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 2 | 0.0323 |
| 1 | ENEMA | 2 | 0.0198 |
| 2 | FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0175 |
| 3 | OMEPRAZOLE AND SODIUM BICARBONATE | 28 | 0.0098 |
| 4 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | 1 | 0.0063 |
| 5 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 6 | ATAZANAVIR AND COBICISTAT | 1 | 0.0047 |
| 7 | LANSOPRAZOLE | 665 | 0.0046 |
| 8 | SACCHAROMYCES CEREVISIAE | 1 | 0.0045 |
| 9 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 4 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 681 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 91 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 74 |
| 3 | Loop Diuretic [EPC] | 62 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 51 |
| 5 | Corticosteroid [EPC] | 45 |
| 6 | Calcium Channel Blocker [EPC] | 41 |
| 7 | beta-Adrenergic Blocker [EPC] | 39 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 37 |
| 9 | Benzodiazepine [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 681 | 0.0015 |
| 1 | Sulfonamide Antibacterial [EPC] | 2 | 0.0007 |
| 2 | Anti-coagulant [EPC] | 3 | 0.0005 |
| 3 | Human Platelet-derived Growth Factor [EPC] | 1 | 0.0005 |
| 4 | Vitamin D3 Analog [EPC] | 9 | 0.0005 |
| 5 | Anthelmintic [EPC] | 1 | 0.0005 |
| 6 | Chloride Channel Activator [EPC] | 3 | 0.0004 |
| 7 | Vitamin D2 Analog [EPC] | 5 | 0.0004 |
| 8 | Thiazide-like Diuretic [EPC] | 11 | 0.0004 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0003 |